C50.8 Malignant neoplasm, overlapping lesion of breast - analogs
| Description «C50.8 Malignant neoplasm, overlapping lesion of breast» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C50.9 Malignant neoplasm, breast, unspecified
- 30% Compare C50.4 Malignant neoplasm, upper-outer quadrant of breast
- 30% Compare C50 Malignant neoplasm of breast
- 30% Compare C50.1 Malignant neoplasm, central portion of breast
- 30% Compare C50.2 Malignant neoplasm, upper-inner quadrant of breast
- 30% Compare C50.5 Malignant neoplasm, lower-outer quadrant of breast
- 30% Compare C50.3 Malignant neoplasm, lower-inner quadrant of breast
- 30% Compare C50.6 Malignant neoplasm, axillary tail of breast
- 23% Compare C50.0 Malignant neoplasm, nipple and areola
- 20% Compare C49.3 Malignant neoplasm, connective and soft tissue of thorax
- 20% Compare C30-C39 Malignant neoplasms of the respiratory and thoracic organs
- 20% Compare C47.3 Malignant neoplasm, peripheral nerves of thorax
- 15% Compare C15.1 Malignant neoplasm, thoracic part of oesophagus
- 15% Compare D05 Carcinoma in situ of breast
- 13% Compare C76.1 Malignant neoplasm, thorax
- 10% Compare C54.1 Malignant neoplasm, endometrium
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C71.8 Malignant neoplasm, overlapping lesion of brain
- 10% Compare C92.7 Other myeloid leukaemia
- 10% Compare C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
- 10% Compare C22.9 Malignant neoplasm, liver, unspecified
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare C93 Monocytic leukaemia
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare C92 Myeloid leukaemia
- 10% Compare C44.5 Malignant neoplasm, skin of trunk
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C51.9 Malignant neoplasm, vulva, unspecified
- 10% Compare C25.1 Malignant neoplasm, body of pancreas
- 10% Compare C40.9 Malignant neoplasm, bone and articular cartilage of limb, unspecified
- 10% Compare C94.7 Other specified leukaemias
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare C40 Malignant neoplasm of bone and articular cartilage of limbs
- 10% Compare C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- 10% Compare C38.3 Malignant neoplasm, mediastinum, part unspecified
- 10% Compare C71 Malignant neoplasm of brain
- 10% Compare C22.7 Malignant neoplasm, other specified carcinomas of liver
- 10% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C41.0 Malignant neoplasm, bones of skull and face
- 10% Compare C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
- 10% Compare C79.3 Secondary malignant neoplasm of brain and cerebral meninges
- 10% Compare C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissues
- 10% Compare C91 Lymphoid leukaemia
- 10% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
- 10% Compare C25.2 Malignant neoplasm, tail of pancreas
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.